Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Clinical Study to Evaluate the Efficacy and Safety of GNS-212-E in Bowel Preparation for Colonoscopy
Phase 3
Completed
- Conditions
- ColonoscopyBowel Preparation
- Interventions
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Gunkang Pharmaceuticals, Inc
- Target Recruit Count
- 318
- Registration Number
- NCT06317350
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
News
No news found